Design Issues in Drug Development
10 April 2002
a one-day scientific meeting organised by
Statisticians in the Pharmaceutical Industry (PSI)
Venue:
RSA Durham St Auditorium
Durham House St
Off The Strand
London WC2N 6EZ
Agenda:
09.15 - 9.45 Registration
09.45 Opening Remarks
9.50 - 10.30 Trupti Trivedi, (GlaxoSmithKline)
Factors for Consideration in the Design of Antiviral Programs
10.30 - 11.10 Peter Colman, (Pfizer)
Partially Balanced Incomplete Block Designs in Clinical
Pharmacology.
11.10 - 11.35 Coffee
11.35 - 12.15 Prof. Peter W. Jones, (Keele University)
Evaluation of Adaptive Designs.
12.15 - 13.20 Lunch
13.20 - 14.00 Prof. John Whitehead and Dr Yinghui Zhou, (Reading
University)
Bayesian Procedures for Dose-Escalation
in Phase I Clinical Trials
14.00 - 14.40 Dr Nigel Stallard, (Reading University)
A Decision-Theoretic Approach for Phase II Clinical
Trials with Multiple Endpoints
14.40 - 15.00 Tea
15.00 - 15.40 Rob Hemmings, (Medicines Control
Agency)
A Single Answer to a Multiplicity of
Problems?
15.40 - 16.20 Paul Silcocks, (PAREXEL)
Epidemiology in Drug Development
16.20 Meeting Close
Registration:
PSI Members
£176.25 (inc. £26.25 VAT)
Non-Members
£188.00 (inc £28.00 VAT)
Fee includes lunch, refreshments and VAT
For further details please contact:
Lynn Devall.
Tel: +44 (0)1625 511750
Fax: +44 (0)1625 267879
[log in to unmask]
|